Meeder Asset Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-96
| Closed | -$1K | – | 2423 |
|
2020
Q3 | $1K | Hold |
96
| – | – | ﹤0.01% | 2103 |
|
2020
Q2 | $1K | Sell |
96
-371
| -79% | -$3.87K | ﹤0.01% | 1993 |
|
2020
Q1 | $3K | Buy |
+467
| New | +$3K | ﹤0.01% | 2036 |
|
2019
Q4 | – | Sell |
-476
| Closed | -$5K | – | 2503 |
|
2019
Q3 | $5K | Sell |
476
-342
| -42% | -$3.59K | ﹤0.01% | 1795 |
|
2019
Q2 | $8K | Sell |
818
-905
| -53% | -$8.85K | ﹤0.01% | 1542 |
|
2019
Q1 | $22K | Sell |
1,723
-5,849
| -77% | -$74.7K | ﹤0.01% | 1061 |
|
2018
Q4 | $114K | Sell |
7,572
-439
| -5% | -$6.61K | 0.01% | 606 |
|
2018
Q3 | $160K | Sell |
8,011
-936
| -10% | -$18.7K | 0.01% | 535 |
|
2018
Q2 | $174K | Buy |
8,947
+7,652
| +591% | +$149K | 0.02% | 532 |
|
2018
Q1 | $26K | Sell |
1,295
-106
| -8% | -$2.13K | ﹤0.01% | 826 |
|
2017
Q4 | $18K | Buy |
1,401
+366
| +35% | +$4.7K | ﹤0.01% | 958 |
|
2017
Q3 | $19K | Buy |
1,035
+226
| +28% | +$4.15K | ﹤0.01% | 919 |
|
2017
Q2 | $15K | Buy |
809
+773
| +2,147% | +$14.3K | ﹤0.01% | 895 |
|
2017
Q1 | $1K | Buy |
+36
| New | +$1K | ﹤0.01% | 1596 |
|
2016
Q2 | – | Sell |
-3,286
| Closed | -$77K | – | 985 |
|
2016
Q1 | $77K | Sell |
3,286
-1,460
| -31% | -$34.2K | 0.01% | 711 |
|
2015
Q4 | $143K | Buy |
4,746
+2,527
| +114% | +$76.1K | 0.01% | 579 |
|
2015
Q3 | $88K | Sell |
2,219
-36,644
| -94% | -$1.45M | 0.01% | 607 |
|
2015
Q2 | $2.68M | Buy |
+38,863
| New | +$2.68M | 0.27% | 87 |
|